NEDD9 overexpression is associated with the progression of and an unfavorable prognosis in epithelial ovarian cancer

Human Pathology

Volumn 45, Issue 2, 2014, Pages 401-408

  Wang, Haixia ^a   Mu, Xiaoling ^a   Zhou, Suiyang ^a   Zhang, Jing ^a   Dai, Jiemin ^a   Tang, Liangdan ^a   Xiao, Lin ^a   Duan, Zhaoning ^a   Jia, Li ^b   Chen, Shu ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b SOUTHWEST MEDICAL UNIVERSITY   (China)

Author keywords

Epithelial ovarian cancer; Invasion; Metastasis; NEDD9; Prognosis

Indexed keywords

NEURAL PRECURSOR CELL EXPRESSED DEVELOPMENTALLY DOWN REGULATED 9 PROTEIN; SCAFFOLD PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER PROGNOSIS; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MIDDLE AGED; OVARY CARCINOMA; PROTEIN EXPRESSION; WESTERN BLOTTING;

EPITHELIAL OVARIAN CANCER; INVASION; METASTASIS; NEDD9; PROGNOSIS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; DISEASE PROGRESSION; FEMALE; HUMANS; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PHOSPHOPROTEINS; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84892776822     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2013.10.005     Document Type: Article

References (28)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J Clin 61 2011 69 90
2. M. Smoter, L. Bodnar, and B.O. Grala et al. Tau protein as a potential predictive marker in epithelial ovarian cancer patients treated with paclitaxel/platinum first-line chemotherapy J Exp Clin Cancer Res 32 2013 25
3. H. Bonnefoi, R.P. A'Hern, and C. Fisher et al. Natural history of stage IV epithelial ovarian cancer J Clin Oncol 17 1999 767 775
4. S. Bhoola, and W.J. Hoskins Diagnosis and management of epithelial ovarian cancer Obstet Gynecol 107 2006 1399 1410
5. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2013 CA Cancer J Clin 63 2013 11 30
6. G.M. O'Neill, and E.A. Golemis Proteolysis of the docking protein HEF1 and implications for focal adhesion dynamics Mol Cell Biol 21 2001 5094 5108
7. G.A. van Seventer, H.J. Salman, and S.F. Law et al. Focal adhesion kinase regulates beta1 integrin dependent migration through an HEF1 effector pathway Eur J Immun 31 2001 1417 1427
8. S.J. Fashena, M.B. Einarson, G.M. O'Neill, C.P. Patriotis, and E.A. Golemis Dissection of HEF1-dependent functions in motility and transcriptional regulation J Cell Sci 115 2002 99 111
9. M. Natarajan, J.E. Stewart, and E.A. Golemis et al. HEF1 is a necessary and specific downstream effector of FAK that promotes the migration of glioblastoma cells Oncogene 25 2006 1721 1732
10. M. Kim, J.D. Gans, and C. Nogueira et al. Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene Cell 125 2006 1269 1281
11. E. Izumchenko, M.K. Singh, and O.V. Plotnikova et al. NEDD9 promotes oncogenic signaling in mammary tumor development Cancer Res 69 2009 7198 7206
12. J.T. Lucas Jr., B.P. Salimath, M.G. Slomiany, and S.A. Rosenzweig Regulation of invasive behavior by vascular endothelial growth factor is HEF1-dependent Oncogene 29 2010 4449 4459
13. S.H. Kim, D. Xia, S.W. Kim, V. Holla, D.G. Menter, and R.N. Dubois Human enhancer of filamentation 1 is a mediator of hypoxia-inducible factor-1alpha-mediated migration in colorectal carcinoma cells Cancer Res 70 2010 4054 4063
14. D. Xia, V.R. Holla, D. Wang, D.G. Menter, and R.N. DuBois HEF1 is a crucial mediator of the proliferative effects of prostaglandin E(2) on colon cancer cells Cancer Res 70 2010 824 831
15. H. Donninger, T. Bonome, and M. Radonovich et al. Whole genome expression profiling of advance stage papillary serous ovarian cancer reveals activated pathways Oncogene 23 2004 8065 8077
16. J. Zhang, L.D. Tang, and L. Shen et al. High level of WAVE1 expression is associated with tumor aggressiveness and unfavorable prognosis of epithelial ovarian cancer Gynecol Oncol 127 2012 223 230
17. S.F. Law, J. Estojak, B. Wang, T. Mysliwiec, G.D. Kruh, and E.A. Golemis Human enhancer of filamentation 1 (HEF1), a novel p130Cas-like docking protein, associates with FAK, and induces pseudohyphal growth in yeast Mol Cell Biol 16 1996 3327 3337
18. J.X. Chang, F. Gao, G.Q. Zhao, and G.J. Zhang Expression and clinical significance of NEDD9 in lung tissues Med Oncol 29 2012 2654 2660
19. L. Xia, W. Huang, and D. Tian et al. Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma Hepatology 57 2013 610 624
20. Y. Li, J.H. Bavarva, and Z. Wang et al. HEF1, a novel target of Wnt signaling, promotes colonic cell migration and cancer progression Oncogene 30 2011 2633 2643
21. M.C. Speranza, V. Frattini, and F. Pisati et al. NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma Oncotarget 3 2012 723 734
22. C. Kong, C. Wang, and L. Wang et al. NEDD9 is a positive regulator of epithelial-mesenchymal transition and promotes invasion in aggressive breast cancer PLoS One 6 2011 e22666
23. A.K. Sood, E.A. Setfor, and Flether Ms et al. Molecular determinants of ovarian cancer plasticity Am J Pathol 158 2001 1279 1288
24. S.F. Law, Y.Z. Zhang, A.J. Klein-Szanto, and E.A. Golemis Cell cycle-regulated processing of HEF1 to multiple protein forms differentially targeted to multiple subcellular compartments Mol Cell Biol 18 1998 3540 3551
25. S.F. Law, G.M. O'Neill, S.J. Fashena, M.B. Einarson, and E.A. Golemis The docking protein HEF1/NEDD9/CAS-L is an apoptotic mediator at focal adhesion sites Mol Cell Biol 20 2000 5184
26. E.N. Pugacheva, and E.A. Golemis The focal adhesion scaffolding protein HEF1/NEDD9/CAS-L regulates activation of the Aurora-A and Nek2 kinases at the centrosome Nat Cell Biol 7 2005 937 946
27. M. Singh, L. Cowell, S. Seo, G. O'Neill, and E. Golemis Molecular basis for HEF1/NEDD9/Cas-L action as a multifunctional coordinator of invasion, apoptosis and cell cycle Cell Biochem Biophys 48 2007 54 72
28. Y.Z. Xue, Y.Y. Sheng, and Z.L. Liu et al. Expression of NEDD9 in pancreatic ductal adenocarcinoma and its clinical significance Tumour Biol 34 2012 895 899